SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment

Oryzon Genomics SA BME:ORY

ORY